Mark Durand
2015
In 2015, Mark Durand earned a total compensation of $964.8K as Former Executive Vice President and Chief Financial Officer at Sorrento Therapeutics.
Compensation breakdown
| Option Awards | $706,800 |
|---|---|
| Salary | $67,046 |
| Other | $190,963 |
| Total | $964,809 |
Durand received $706.8K in option awards, accounting for 73% of the total pay in 2015.
Durand also received $67K in salary and $191K in other compensation.
Rankings
In 2015, Mark Durand's compensation ranked 8,142nd out of 13,638 executives tracked by ExecPay. In other words, Durand earned more than 40.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,142 out of 13,638 | 40th |
Division Manufacturing | 3,103 out of 5,190 | 40th |
Major group Chemicals And Allied Products | 1,124 out of 1,854 | 39th |
Industry group Drugs | 906 out of 1,528 | 41st |
Industry Biological Products, Except Diagnostic Substances | 156 out of 254 | 39th |
Source: SEC filing on May 13, 2016.
Durand's colleagues
We found seven more compensation records of executives who worked with Mark Durand at Sorrento Therapeutics in 2015.
2015
Henry Ji
Sorrento Therapeutics
Chief Executive Officer
2015
David Miao
Sorrento Therapeutics
Former SVP, Head of ADC Development
2015
Jeffrey Su
Sorrento Therapeutics
Chief Operating Officer
2015
George Ng
Sorrento Therapeutics
Chief Administrative Officer
2015
Mike Royal
Sorrento Therapeutics
Former EVP, Clinical and Regulatory Affairs
2015
Richard Vincent
Sorrento Therapeutics
Chief Financial Officer
2015
Douglas Langston
Sorrento Therapeutics